Source:http://linkedlifedata.com/resource/pubmed/id/17388706
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-28
|
pubmed:abstractText |
Evidence that clinical treatment reduces suicide risk in major depressive disorder (MDD) is limited and inconsistent. Since lithium shows major antisuicidal effects in bipolar disorders and in heterogeneous mood disorder samples, we evaluated evidence of antisuicidal effects of lithium in patients with recurrent MDD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1555-2101
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
380-3
|
pubmed:meshHeading |
pubmed-meshheading:17388706-Antidepressive Agents,
pubmed-meshheading:17388706-Depressive Disorder, Major,
pubmed-meshheading:17388706-Humans,
pubmed-meshheading:17388706-Lithium Carbonate,
pubmed-meshheading:17388706-Recurrence,
pubmed-meshheading:17388706-Risk Assessment,
pubmed-meshheading:17388706-Suicide, Attempted
|
pubmed:year |
2007
|
pubmed:articleTitle |
Lithium treatment reduces suicide risk in recurrent major depressive disorder.
|
pubmed:affiliation |
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|